LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media
The findings from the clinical study, conducted Thai Binh University of Medicine and Pharmacy in collaboration with other institutions, was published on January 27, 2025, in Scientific Reports-Nature, a renowned journal under the Nature Portfolio (UK). The results demonstrated significant effectiveness in children within just 3–7 days of use. Additionally, data also showed positive improvements in adults, highlighting the product's potential for broader application in the future.
The study was carried out from November 2023 to December 2024 with the participation of 126 patients, including both children and adults. Among children with acute rhinosinusitis and perforated acute otitis media, the treatment results were particularly notable: after 3 days of using LiveSpo® NAVAX, nasal congestion decreased by 68%, twice as much as the saline group. After 7 days, 97% of the children had no more nasal discharge, and 100% had no more ear discharge. The concentration of pathogenic bacteria Streptococcus pneumoniae in nasal and ear secretions dropped more than 1,200 times. Importantly, no side effects were recorded during the entire trial – even in children with weakened immune systems.
In the adult group with acute sinusitis, symptoms such as nasal congestion, facial pain, and purulent discharge improved significantly after 3 days of use – with reductions of 53%, 78%, and 61%, respectively. After 7 days, 91% of patients no longer experienced nasal discharge. Laboratory results showed a substantial reduction in pathogenic bacteria: Streptococcus pneumoniae decreased over 380-fold and Haemophilus influenzae decreased over 49,000-fold compared to the Control group receiving physiological saline
According to the research team, the effectiveness of LiveSpo® NAVAX origins from its ability to modulate local inflammatory responses and enhance mucosal immunity through the competitive biological mechanism of spore-forming Bacillus probiotics. Inflammatory markers such as IL-6, IL-8, and TNF-α significantly decreased, while levels of IgA – a key protective antibody at the mucosal surface – increased, contributing to the restoration of the nose and ear's natural defense barrier.
This study not only adds to the growing body of scientific evidence supporting LiveSpo® NAVAX's efficacy in respiratory care but also affirms Vietnam's biomedical research capabilities on the international scientific map. It paves the way for a safe, sustainable respiratory treatment alternative that reduces reliance on antibiotics – especially for vulnerable groups like children.
Dr. Nguyen Hoa Anh, Chairman and Founder of LiveSpo Pharma, shared:
'At LiveSpo, we prioritize the research and development of internationally standardized products, combining modern medicine with advanced probiotic technology to deliver safe and effective health solutions for the community – all with a vision of A Future Without Antibiotics.'
References: Khieu TH, Le DP, Nguyen BT, Ngo BT, Chu HT, Truong DM, Nguyen HM, Nguyen AH, Pham TD, Van Nguyen AT. Alleviating symptoms of paediatric acute rhinosinusitis and acute otitis media with otorrhea using nasal-spraying Bacillus probiotics: a randomized controlled trial. Sci Rep. 2025 Jan 27;15(1):3410. doi: 10.1038/s41598-025-87372-2. PMID: 39870748; PMCID: PMC11772584.
Hashtag: #LiveSpo
https://livespo.com
The issuer is solely responsible for the content of this announcement.
About LiveSpo Pharma
LiveSpo is an R&D, manufacturing, and distribution brand of Clinically Proven Medical Probiotics, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for 'A Future Without Antibiotics'.
Our vision: In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences. Established since 2010 by Dr. Nguyen Hoa Anh (Dr. ANH) and his colleagues, LiveSpo has remained steadfast in its belief that Live Probiotic Spores – Spobiotic – will pave the way to a future without antibiotics for everyone.
Hotline: 1800.088808
Website: LiveSpo.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
a day ago
- Al Etihad
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
3 June 2025 14:30 ABU DHABI (ALETIHAD)M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood approach does not replace but rather complements routine cancer screenings, and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said, 'This collaboration reflects our vision of democratising health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalised care.'Sameh El Fangary, Cluster President GCC of AstraZeneca, stated, "Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimising patient pathways from detection to therapy.' Ross Muken, President of SOPHiA GENETICS, said, "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalise care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." Source: Aletihad - Abu Dhabi
Khaleej Times
3 days ago
- Khaleej Times
The art of seasonal scents: Choosing the right perfume for every season
Perfume is a deeply personal luxury, an invisible signature that lingers long after you leave the room. It has the power to uplift your mood, spark memories, and transform even the most ordinary days into sensory moments. From the delicate burst of florals in spring to the warm embrace of oud in winter, the right fragrance can capture the essence of a season with just one spritz. As seasons shift, so too does the way perfume interacts with your skin and environment. Summer's warmth can intensify lighter scents, making citrus and aquatic notes feel fresh and vibrant, while cooler months are perfect for rich, full-bodied compositions like amber, musk, and spice. Wearing perfume in harmony with the weather not only enhances its impact but also adds a touch of sophistication to your daily ritual. With the help an expert insight, you can explore the delicate balance between choosing fragrances that match the mood of each season, while also being kind to your skin and body. Whether you're layering your signature scent or discovering new seasonal favorites, let this guide inspire a more mindful and elegant way to wear fragrance; one that complements your style, the seasons, and your sense of wellbeing. Spring: A time for florals and fresh starts Spring welcomes lighter, breezier notes that mirror the rebirth of nature. Think peonies, lilies, green tea, or citrusy neroli. After the musky cocoon of winter, your body and nose crave something fresher. However, if you're prone to allergies, this season might come with a caveat. Dr Suresh Puri, Consultant Pulmonologist and Internal Medicine at JTS Medical Centre, Dubai, advises caution with fragrance choices, particularly for those with health sensitivities. 'Use scent-free products, try avoiding strong perfumes including smoky (Bakhur) fragrance,' he suggests. As some stronger scents may trigger respiratory reactions and create a stuffy indoor environment, especially if ventilation is poor. For spring, alcohol-free body mists or eau de toilette versions of your favorite fragrances; are suggested as they're usually less concentrated and less likely to overwhelm. Summer: Light, airy, and skin-safe The heat of summer calls for crisp, clean fragrances that won't become cloying in the sun. Popular choices include marine notes, citrus, and fruity blends like watermelon or grapefruit. But with increased sweating and sun exposure, fragrance application becomes tricky, especially for people with sensitive skin. Dr Teena Mathew, Specialist Dermatologist at JTS Medical Centre, Dubai, highlights the importance of skin health when using perfumes. 'For people with sensitive skin wishing to use fragrances, it is best to conduct a usage test. Apply it to a small inconspicuous area for two weeks. If there is no reaction, then it should be safe to use,' she explains. She also emphasises the need for proper skin hydration: 'It is important to keep the skin well moisturised since dry skin can precipitate irritation.' In other words, layering a good unscented moisturiser underneath your fragrance not only helps the scent last longer but also forms a barrier that protects the skin. So, for summers, it's best to opt for oil-based perfumes — they tend to be gentler on the skin and evaporate less quickly. Autumn: Warm, spicy, and grounding As temperatures drop and the air gets crisp, we begin to crave more warmth and that extends to our fragrance choices. Autumn is the season of vanilla, amber, sandalwood, and fig. These rich, spicy, and slightly sweet aromas mimic the cozy feeling of sweater weather. This is also a good time to explore niche or artisanal scents that evoke earthy tones and natural elements. But it's important to be mindful of where and how you apply these stronger perfumes. For individuals with sensitive skin or eczema, direct application on pulse points like the neck or behind the ears can trigger irritation. Dr Mathew suggests, 'Spraying fragrance on clothes instead of directly on the skin can help minimise contact with potential irritants.' Just be sure to test it on a small patch of fabric first to avoid staining. In cooler months, your skin tends to be drier. 'It is also important is to keep the skin well moisturised since dry skin can precipitate skin irritation,' she added. Winter: Bold, deep, and intimate Winter invites bold fragrances with depth; think oud, patchouli, leather, musk, and incense. These perfumes shine in colder temperatures and linger longer in the dry winter air. However, heavier scents can sometimes feel overwhelming, especially indoors or in confined spaces. Dr Puri warns against using smoky or overpowering scents. 'Have a well-ventilated home and workplace environment,' he advises, adding that scent-heavy spaces can negatively affect respiratory health. This is especially relevant during the holiday season when candles, incense, and perfumes are used simultaneously. A good rule of thumb is to balance your olfactory space, if you're lighting a strongly-scented candle, maybe skip the heavy perfume that day. Layering is key in winter. Start with a scented body wash, follow up with a matching lotion, and finish with a spritz of perfume to lock in the fragrance all day. Year-round wellness: Finding balance with fragrance No matter the season, your fragrance should enhance your day. With the rise of clean beauty and dermatologically tested perfumes, consumers now have access to options that are safer for both the skin and the lungs. If you have asthma, allergies, or sensitive skin, patch testing is essential. As Dr Mathew stresses, 'A two-week trial on a small skin area can help detect any delayed allergic reactions.' It may seem tedious, but it's worth it if it saves you from irritation or discomfort. Equally important is ventilation. 'Avoid strong perfumes and ensure your environment is well-ventilated,' says Dr Puri. This small habit can significantly improve indoor air quality and overall wellbeing, especially if you use fragrance daily. You might also consider scented hair mists, lightly fragranced deodorants, or diffuser oils in your personal space to maintain a subtle and pleasant scent. Scent with sensibility Lastly, wearing perfume isn't just about smelling good; it's about feeling good too. It's about understanding your body, your skin's needs, and the subtle ways your surroundings shape how a scent is received. A well-chosen fragrance can be a quiet act of self-care, a daily ritual that speaks to your mood, your story, and your sense of place. By tuning into the rhythm of the seasons and being mindful of your skin's sensitivity and others' comfort, you transform perfume from a fleeting indulgence into something more meaningful. You give it thought, intention, and grace. So, whether you're layering notes of jasmine on a spring morning or wrapping yourself in the velvet of oud on a winter's night, let your scent echo something deeper, your awareness, your wellbeing, and your respect for those around you. Because in a world full of noise, sometimes the softest things like a well-chosen fragrance can leave the strongest impression.
Arabian Post
21-05-2025
- Arabian Post
Uni-Bio Science Group Receives NMPA Approval for 金因康® (Diquafosol Sodium Eye Drops), Advancing Dry Eye Syndrome Treatment in China
HONG KONG SAR – EQS Newswire – 21 May 2025 – Uni-Bio Science Group Limited (the 'Company', together with its subsidiaries, the 'Group') proudly announces that its new ophthalmology product, 金因康(Diquafosol Sodium Eye Drops), has received marketing approval from the China National Medical Products Administration (NMPA) [Approval Number: 國藥准字H20254149]. This milestone strengthens the Group's portfolio in ophthalmology, addressing the growing demand for innovative treatments in China's dry eye syndrome market, which affects an estimated 360 million individuals. As the Group's second ophthalmology drug following GeneSoft®, 金因康® addresses the underlying causes of dry eye syndrome by activating P2Y2 receptors to stimulate tear fluid and mucin secretion. It offers: Improved tear layer normalization and corneal epithelial repair. Treatment for patients with dry eye accompanied by abnormal tear-associated corneal epithelial defects. A next-generation option for more effective and patient-friendly care. China's dry eye syndrome market is projected to surpass RMB 42 billion by 2030, growing at a CAGR of 28.4%, driven by increased screen time and evolving lifestyles. 金因康® is well-positioned to capture this growing demand with its proven efficacy and safety, widely recognized since the originator launched in Japan in 2010. ADVERTISEMENT To ensure rapid market penetration, the Group has expanded its sales force and integrated resources across hospitals, pharmacies, and e-commerce platforms. Strategic partnerships with API suppliers have secured high-quality raw materials at competitive costs, further enhancing 金因康®'s affordability and market competitiveness. Looking ahead, Uni-Bio Science Group will continue to focus on clinical needs and invest in R&D to expand its ophthalmic drug pipeline. With over 20 years of technological expertise, the Group is committed to delivering high-quality medical solutions, raising the standards of ophthalmic care, and solidifying its leadership in China's growing ophthalmology market. Hashtag: #Uni-BioScience The issuer is solely responsible for the content of this announcement. About Uni-Bio Science Group Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and sales of pharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has three GMP manufacturing bases in Beijing, Dongguan and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology. Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690. About 金因康® Diquafosol Sodium Eye Drops are a medication for treating dry eye disease and are suitable for patients diagnosed with dry eye accompanied by abnormal tear-associated corneal epithelial defects. Diquafosol Sodium represents the next generation of dry eye medication, offering cutting-edge therapy through its novel mechanism as a P2Y2 receptor agonist, stimulating tear and mucin secretion. This addresses the underlying causes of dry eye syndrome, normalizing the tear layer and improving corneal epithelial damage.
